Approval · Notice of Compliance 14451 · 2013
VICTRELIS: Notice of Compliance 14451
Issued May 16, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14451
- Date
- May 16, 2013
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph following the results of the anemia management study (P06086) and results from the ongoing study in previous treatment failures, including null responders (P05514)
- Therapeutic class
- Hepatitis C virus (hcv) protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VICTRELIS | Not yet assigned | — |
Medicinal ingredients
- BOCEPREVIR 200 MG per CAP